Silicon Laboratories, Inc. $SLAB Shares Sold by Northern Trust Corp

Key Points

• Northern Trust Corp has reduced its stake in Silicon Laboratories, Inc. by 3.6%, owning approximately 1.23% of the company after selling 15,074 shares in the 1st quarter.
• Silicon Laboratories experienced a 32.6% increase in revenue year-over-year, reporting $192.85 million for the last quarter, and earnings per share (EPS) of $0.11, exceeding analysts' estimates.
• Wall Street analysts have varied ratings on Silicon Laboratories, with a consensus of a "Moderate Buy" and a target price of $151.13, reflecting a mixed outlook for the company's stock.

Northern Trust Corp lowered its position in shares of Silicon Laboratories, Inc. (NASDAQ:SLAB - Free Report) by 3.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 399,933 shares of the semiconductor company's stock after selling 15,074 shares during the period. Northern Trust Corp owned 1.23% of Silicon Laboratories worth $45,020,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of SLAB. GAMMA Investing LLC lifted its position in Silicon Laboratories by 99.6% in the first quarter. GAMMA Investing LLC now owns 1,126 shares of the semiconductor company's stock valued at $127,000 after acquiring an additional 562 shares during the last quarter. Principal Financial Group Inc. lifted its position in Silicon Laboratories by 72.2% in the first quarter. Principal Financial Group Inc. now owns 129,911 shares of the semiconductor company's stock valued at $14,624,000 after acquiring an additional 54,463 shares during the last quarter. KBC Group NV lifted its position in Silicon Laboratories by 27.1% in the first quarter. KBC Group NV now owns 1,625 shares of the semiconductor company's stock valued at $183,000 after acquiring an additional 346 shares during the last quarter. Oppenheimer Asset Management Inc. lifted its position in Silicon Laboratories by 2.9% in the first quarter. Oppenheimer Asset Management Inc. now owns 7,379 shares of the semiconductor company's stock valued at $831,000 after acquiring an additional 210 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC lifted its position in Silicon Laboratories by 9.7% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 2,334 shares of the semiconductor company's stock valued at $290,000 after acquiring an additional 206 shares during the last quarter.

Insider Activity

In other news, SVP Brandon Tolany sold 8,000 shares of the business's stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $145.23, for a total transaction of $1,161,840.00. Following the transaction, the senior vice president directly owned 62,328 shares in the company, valued at $9,051,895.44. The trade was a 11.38% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders have sold 12,070 shares of company stock worth $1,703,472 in the last quarter. Insiders own 1.60% of the company's stock.

Silicon Laboratories Price Performance

Shares of NASDAQ:SLAB traded down $4.06 on Tuesday, reaching $130.29. The company's stock had a trading volume of 369,772 shares, compared to its average volume of 350,084. The stock's 50-day moving average is $138.32 and its two-hundred day moving average is $127.27. Silicon Laboratories, Inc. has a 52-week low of $82.82 and a 52-week high of $160.00. The stock has a market capitalization of $4.27 billion, a P/E ratio of -40.46 and a beta of 1.52.

Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last announced its earnings results on Tuesday, August 5th. The semiconductor company reported $0.11 EPS for the quarter, beating analysts' consensus estimates of $0.09 by $0.02. Silicon Laboratories had a negative net margin of 14.88% and a negative return on equity of 7.21%. The business had revenue of $192.85 million during the quarter, compared to analysts' expectations of $192.57 million. During the same period in the prior year, the company earned ($0.56) earnings per share. The business's revenue was up 32.6% compared to the same quarter last year. Silicon Laboratories has set its Q3 2025 guidance at 0.200-0.400 EPS. Equities analysts forecast that Silicon Laboratories, Inc. will post -0.97 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the stock. Morgan Stanley reduced their price target on shares of Silicon Laboratories from $157.00 to $144.00 and set an "equal weight" rating for the company in a research report on Wednesday, August 6th. Susquehanna boosted their price target on shares of Silicon Laboratories from $110.00 to $150.00 and gave the company a "neutral" rating in a research report on Tuesday, July 22nd. Needham & Company LLC reissued a "buy" rating and issued a $150.00 price target on shares of Silicon Laboratories in a research report on Wednesday, May 14th. Barclays boosted their price target on shares of Silicon Laboratories from $100.00 to $130.00 and gave the company an "equal weight" rating in a research report on Tuesday, August 5th. Finally, Benchmark reaffirmed a "buy" rating and issued a $160.00 target price on shares of Silicon Laboratories in a report on Tuesday, May 27th. Five investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, Silicon Laboratories presently has a consensus rating of "Moderate Buy" and a consensus target price of $151.13.

Silicon Laboratories Profile

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.